Fair Value Measurements of Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2024

Fair Value Disclosures [Abstract]

Schedule of Carrying Amounts and Fair Values of Financial Instruments

The carrying amounts and fair values of the Company’s financial instruments as of September 30, 2024, are presented below (in thousands):

	Fair Value Measurements
	Level 1		Level 2		Level 3		Total
Assets
Money market accounts*	$	28,044	$	—	$	—	$	28,044
Marketable securities – certificates of deposit		2,263		—		—		2,263
Marketable securities – equity securities		91		—		—		91
I Health call option		—		—		3,907		3,907
Total assets	$	30,398	$	—	$	3,907	$	34,305
Liabilities
Interest rate collar	$	—	$	154	$	—	$	154
AAMG contingent consideration		—		—		3,876		3,876
VOMG contingent consideration		—		—		15		15
DMG remaining equity interest purchase		—		—		8,542		8,542
Sun Labs remaining equity interest purchase		—		—		7,352		7,352
ADSC contingent considerations		—		—		4,138		4,138
CFC contingent considerations		—		—		9,138		9,138
PCCCV contingent considerations		—		—		2,597		2,597
Total liabilities	$	—	$	154	$	35,658	$	35,812

* Included in cash and cash equivalents

The carrying amounts and fair values of the Company’s financial instruments as of December 31, 2023, are presented below (in thousands):

	Fair Value Measurements
	Level 1		Level 2		Level 3		Total
Assets
Money market accounts*	$	4,842	$	—	$	—	$	4,842
Marketable securities – certificates of deposit		2,150		—		—		2,150
Marketable securities – equity securities		348		—		—		348
Total assets	$	7,340	$	—	$	—	$	7,340
Liabilities
AAMG contingent consideration	$	—	$	—	$	5,475	$	5,475
VOMG contingent consideration		—		—		17		17
DMG remaining equity interest purchase		—		—		8,542		8,542
Sun Labs remaining equity interest purchase		—		—		7,802		7,802
Interest rate collar		—		252		—		252
Total liabilities	$	—	$	252	$	21,836	$	22,088

* Included in cash and cash equivalents

Schedule of Change in Fair Value of Level 3 Liabilities

The change in the fair value of Level 3 liabilities for the nine months ended September 30, 2024, was as follows (in thousands):

	Amount
Balance at January 1, 2024	$	21,836
Additions		14,202
Change in fair value of existing Level 3 liabilities		3,643
Settlements		(4,023	)
Balance at September 30, 2024	$	35,658

Schedule of Gain (Loss) on Equity Securities

The components comprising total gains and losses on equity securities are as follows (in thousands) for the periods listed below:

	Three Months Ended September 30,					Nine Months Ended September 30,
	2024		2023			2024			2023
Total gains (losses) recognized on equity securities	$	68	$	(870	)	$	(133	)	$	(6,571	)
Gains (losses) recognized on equity securities sold		65		—			(146	)		—
Unrealized gains (losses) recognized on equity securities held at end of period	$	3	$	(870	)	$	13		$	(6,571	)